Seeking Alpha

Bayer Schering Pharma AG (BYERF.PK)

()

News & PR
Market Currents

Buzz
Twitter: BYERF.PK

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on BYERF.PK

December's Game Plan for Biotech by Justin M. Hall
Historically, playing the drug makers in December has proven to be a safe bet. December ranks first, above August and September, as the best performing month for the iShares Nasdaq Biotechnology (IBB) ETF with average gains of about 8%.Outlined below is a game plan that might help investors... More »
December 1, 2009 • IBB, ENDP, SPPI
Spectrum Pharma: Sales of Zevalin Are Ramping Up by Justin M. Hall
On November 13, Spectrum Pharmaceuticals (SPPI) reported some positive Q3 results. Sales of their non-Hodgkin’s lymphoma (NHL) drug, Zevalin®, which made up more than half of the revenue generated during the quarter, continue to improve significantly.Over the past several months,... More »
November 21, 2009 • SPPI, RHHBY.PK, BIIB
Spectrum Pharmaceuticals: Zevalin Has Blockbuster Potential by Justin M. Hall
A number of positive peer-reviews evaluating Spectrum Pharmaceuticals (SPPI) radio-immunotherapy (RIT), Zevalin® were published this month. The conclusions drawn in these reviews were made from unbiased medical professionals, and indicate that the prospects for Zevalin may be... More »
October 24, 2009 • SPPI, BYERF.PK, RHHBY.PK
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall
As many, who have followed and/or invested in Spectrum Pharmaceuticals (SPPI), know Zevalin® was finally (and thankfully) approved last Friday, September 4 by the FDA for first-line consolidation use in patients with non-Hodgkins lymphoma (NHL). PRELIMINARY FACTSZevalin is the first of... More »
September 11, 2009 • BMY, PFE, OSIP
Spectrum Pharmaceuticals: The Labor Day Catalyst by Justin M. Hall
This Labor Day, September 7, Spectrum Pharmaceuticals (SPPI) expects an FDA decision for their non-Hodgkin’s lymphoma (NHL) radio-immunotherapeutic (RIT), Zevalin®. The consensus held by most investors, analysts and commentators is that Zevalin will be approved as a... More »
August 20, 2009 • SPPI, CTIC, BIIB
Spectrum Pharmaceuticals: Rumor of Buyout Talks, Speculation Persists by Justin M. Hall
An unconfirmed rumor about a possible Spectrum Pharmaceuticals (SPPI) buyout was reported by TheFlyontheWall during Friday's session. This rumor also supports the ongoing speculation that SPPI could be acquired by a larger specialty drug maker following... More »
August 9, 2009 • SPPI, BYERF.PK, BMY
Small Cancer Drug Makers Are Knocking It Out of the Park by Justin M. Hall
In case some didn’t get the memo, the smaller drug makers have been on fire this summer. On July 7, the Lucky 13 Buys list was unleashed. Since that time, SuperGen (SUPG) and Ariad Pharamaceuticals (ARIA) have each topped the list with gains of 45% and 85%, respectively. In... More »
August 4, 2009 • ONTY, MRK, ARIA
Spectrum Pharmaceuticals: Consensus, SPPI Is a Possible Acquisition Target by Justin M. Hall
A consensus appears to be forming with regard to Spectrum Pharmaceuticals (SPPI). Financially sound SPPI could be targeted for acquisition by Bayer (BYERF.PK) or another specialty drug maker.JULY 31, 2009 On Friday July 31, Jonathan Moreland covered... More »
August 1, 2009 • SPPI, BMY, BYERF.PK

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Bayer Schering Pharma AG (BYERF.PK)

Instablog posts on BYERF.PK

December's Game Plan for Biotech by Justin M. Hall

Spectrum Pharma: Sales of Zevalin Are Ramping Up by Justin M. Hall

Spectrum Pharmaceuticals: Zevalin Has Blockbuster Potential by Justin M. Hall

Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall

Spectrum Pharmaceuticals: The Labor Day Catalyst by Justin M. Hall

Spectrum Pharmaceuticals: Rumor of Buyout Talks, Speculation Persists by Justin M. Hall

Small Cancer Drug Makers Are Knocking It Out of the Park by Justin M. Hall

Spectrum Pharmaceuticals: Consensus, SPPI Is a Possible Acquisition Target by Justin M. Hall

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers